Brief: Neuroone® Receives FDA 510(K) Clearance To Market Its Evo® Seeg System For Less Than 30 Day Use

Neuroone Medical Technologies

25/10/2022 14:05

Oct 25 (Reuters) - Neuroone Medical Technologies Corp
 NMTC.O :
    * NEUROONE® RECEIVES FDA 510(K) CLEARANCE TO MARKET ITS EVO®
SEEG
SYSTEM FOR LESS THAN 30 DAY USE
    * NEUROONE MEDICAL TECHNOLOGIES CORP - FOCUSED ON
MANUFACTURING
RAMP FOR COMMERCIALIZATION IN PARTNERSHIP WITH ZIMMER BIOMET

Source text for Eikon:  ID:nPn8kGlY8a 
Further company coverage:  NMTC.O 
 ((Reuters.Briefs@thomsonreuters.com;;))